Discrepancies Between Clearance Summaries and Marketing Materials of Software-Enabled Medical Devices Cleared by the US Food and Drug Administration
JAMA Network Open · 2023
DOI: 10.1001/jamanetworkopen.2023.21753 ↗Kurz gefasst
Kommentar in der Zeitschrift JAMA Network Open, 2023. Verfasst von Nigam H Shah und 1 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Excellence Research Center, Department of Medicine, Stanford University, Stanford, California. Hauptthemen laut MEDLINE: Software, Marketing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Marketing and FDA Clearance of Artificial Intelligence and Machine Learning Enabled Software in and as Medical Devices
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Clinical Excellence Research Center, Department of Medicine, Stanford University, Stanford, California.
- Technology and Digital Solutions, Stanford Healthcare, Palo Alto, California.
- Department of Health Research and Policy, Stanford Law School and Stanford School of Medicine, Stanford, California.
Zitieren
APA
Shah, N. H., & Mello, M. M. (2023). Discrepancies Between Clearance Summaries and Marketing Materials of Software-Enabled Medical Devices Cleared by the US Food and Drug Administration. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2023.21753
Vancouver
Shah NH, Mello MM. Discrepancies Between Clearance Summaries and Marketing Materials of Software-Enabled Medical Devices Cleared by the US Food and Drug Administration. JAMA Network Open. 2023. doi:10.1001/jamanetworkopen.2023.21753
BibTeX
@article{Shah2023,
author = {Shah, Nigam H and Mello, Michelle M},
title = {Discrepancies Between Clearance Summaries and Marketing Materials of Software-Enabled Medical Devices Cleared by the US Food and Drug Administration},
journal = {JAMA Network Open},
year = {2023},
doi = {10.1001/jamanetworkopen.2023.21753}
}
EUVIMED